Skip to main content

Day: June 1, 2022

Automotive Aftermarket Industry Size [2021-2028] Worth USD 529.88 Billion | Exhibit a CAGR of 3.8%

According to Fortune Business Insights, the global automotive aftermarket industry size is projected to grow from USD 407.51 billion in 2021 to USD 529.88 billion in 2028, at CAGR of 3.8% during forecast period; Increasing Focus on Streamlining Value Chain Processes to Boost the MarketAutomotive Aftermarket Industry Size Automotive Aftermarket Industry SizePune, India, June 01, 2022 (GLOBE NEWSWIRE) — The global Automotive Aftermarket Industry size is set to touch USD 529.88 billion by 2028, exhibiting a CAGR of 3.8% during the forecast period. Growing focus on digitization of aftersales services in the automotive industry will aid the growth of this market, states Fortune Business Insights™ in its report, titled “Automotive Aftermarket Industry Size, Share & Industry Analysis, By Replacement Part Type (Battery, Brake...

Continue reading

Raymond James Completes Acquisition Of TriState Capital Holdings, Inc.

ST. PETERSBURG, Fla., June 01, 2022 (GLOBE NEWSWIRE) — Raymond James Financial (NYSE: RJF) announced today that it has completed the previously announced acquisition of TriState Capital Holdings, Inc. “The strategic and cultural fit between Raymond James and TriState has been continually reinforced as our teams have worked toward this point over the last few months,” said Raymond James Chair and CEO Paul Reilly. “Our collective focus on client-first values and a long-term horizon are unique and a true differentiator for our firms. I’m thrilled to officially welcome TriState Capital to the Raymond James family and look forward to continue growing together.” “We at TriState Capital are as excited about our future as we have ever been, and we are excited about our opportunity to partner with Raymond James who truly values what we...

Continue reading

Raymond James Financial Declares Quarterly Dividend on Preferred Stock

ST. PETERSBURG, Fla., June 01, 2022 (GLOBE NEWSWIRE) — On June 1, 2022, the Raymond James Financial, Inc. (NYSE: RJF) Board of Directors declared a quarterly dividend of $0.421875 per depositary share of 6.75% Fixed-to-Floating Rate Series A Non-Cumulative Perpetual Preferred Stock (NYSE:  RJF PrA) and $0.3984375 per depositary share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock (NYSE:  RJF PrB), in each case payable on July 1, 2022, to holders of record as of June 15, 2022.    About Raymond James Financial, Inc. Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,700 financial...

Continue reading

Itaú Corpbanca Files Material Event Notice announcing the Closing of the Acquisition of MCC companies

SANTIAGO, Chile, June 01, 2022 (GLOBE NEWSWIRE) — ITAÚ CORPBANCA (NYSE: ITCB; SSE: ITAUCORP) announced that it filed today a Material Event Notice reporting the closing of the acquisition of MCC companies –in compliance with the Transaction Agreement– with the Chilean Commission for the Financial Market. The full Material Event Notice is available on the company’s investor relations website at ir.itau.cl. Investor Relations – Itaú Corpbanca+56 (2) 2660-1701 / IR@itau.cl / ir.itau.cl

Continue reading

Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th

SOLANA BEACH, Calif., June 01, 2022 (GLOBE NEWSWIRE) —  Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical-stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting at the LD Micro conference which is being held on June 7– 9, 2022, at the Four Seasons Westlake Village, California. Mr. Gorgas is scheduled to present on Tuesday, June 7, 2022, at 2:30 P.M PT/ 5:30 P.M. ET. The presentation will be webcast live and available for replay at ldinv12.mysequire.com. Management will also be available for one-on-one meetings with qualified investors June 7 and 8, 2022 during the conference.   About Artelo Biosciences Artelo Biosciences, Inc. is a...

Continue reading

Duck Creek Technologies Joins Microsoft Azure Marketplace

Microsoft Azure customers worldwide may access Duck Creek OnDemand and leverage the company’s cloud-based capabilities to remain agile, intelligent and evergreen Boston, June 01, 2022 (GLOBE NEWSWIRE) — Duck Creek Technologies (NASDAQ: DCT), a leading, global technology solutions provider to the property and casualty (P&C) insurance industry, today announces the availability of Duck Creek OnDemand, its cloud-based software-as-a-service (SaaS) solution, in the Microsoft Azure Marketplace. P&C insurance carriers with an existing Microsoft Azure Consumption Commitment (MACC) may fully utilize newly contracted Duck Creek OnDemand spend to contribute to their Azure commitment. Duck Creek offers policy, rating, billing, claims, producer, insights, distribution management, and industry content solutions in the Microsoft Azure...

Continue reading

Brama–Alba porphyry system at Bramaderos Project in Ecuador now 1.1km long, 400m wide and open

OTTAWA, June 01, 2022 (GLOBE NEWSWIRE) — Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP; OTC:CTNXF; FWB:GWN1) is pleased to provide an update on its Bramaderos gold and copper joint venture in southern Ecuador (see Figures 1 and 2) in which it has a 12.5% interest carried by JV partner and project operator Sunstone Metals Ltd. (ASX: STM) through to the start of commercial production (see “About Bramaderos”, below). Figures related to this news release can be seen in PDF format by accessing the version of this release on the Company’s website (www.cornerstoneresources.com) or by clicking on the link below: https://cornerstoneresources.com/site/assets/files/5855/nr22-13figures.pdf. HIGHLIGHTS:Strong assay results received from Brama for holes BMDD0014, 015, 016, 017, and 018:221.6m at 0.43g/t gold,...

Continue reading

Invesco Ltd.: Form 8.3 – John Menzies Plc

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree John Menzies plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

Farmers & Merchants State Bank Announces the Retirement of Edward A. Leininger, EVP & Chief Operating Officer

Benet Rupp Benet Rupp Promoted to Chief Administrative OfficerShalini Singhal Shalini Singhal, Chief Information Officer, to Lead M&A IntegrationsAlexis Smith Alexis Smith Promoted to Chief People OfficerAmy Cover Amy Cover Promoted to Chief Marketing OfficeMolly Miller Molly Miller Promoted to Senior E-Banking & Product Lifecycle ManagerBenet Rupp Promoted to Chief Administrative Officer Shalini Singhal, Chief Information Officer, to Lead M&A Integrations Alexis Smith Promoted to Chief People Officer Amy Cover Promoted to Chief Marketing Officer Molly Miller Promoted to Senior E-Banking & Product Lifecycle ManagerARCHBOLD, Ohio, June 01, 2022 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO) announces the retirement of Edward A. Leininger EVP & Chief Operating...

Continue reading

Cornerstone Pharmaceuticals to Present Pancreatic Cancer, Clear Cell Sarcoma and Biliary Tract Cancer Research Featuring CPI-613® (Devimistat) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Cranbury, NJ, June 01, 2022 (GLOBE NEWSWIRE) — Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced that the Company and its partners will present three abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 3 – June 7, 2022 in Chicago. The three abstracts from Cornerstone’s partners and principal investigators, Mark Agulnik, Vaibhav Sahai and Philip Philip, highlight its ongoing trials studying CPI-613® (devimistat) in clear cell sarcoma and biliary tract cancer, with a special discussion on pancreatic cancer. “We are incredibly proud to have promising research findings to share in the three rare cancer areas that we’re focused on at ASCO’s Annual Meeting,” said Sanjeev...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.